Loading market dashboard
Shoulder Innovations, Inc.
SIHealthcareNYSEUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
The consensus price target hints at a 51.8% upside potential for Shoulder Innovations, Inc. (SI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
[url="]Travel Leisure Co.[/url] (NYSE: TNL), a leading leisure travel company, today announced the groundbreaking of a new Sports Illustrated Resorts destinat
GRAND RAPIDS, Mich., May 26, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, June 9, 2026.
The average of price targets set by Wall Street analysts indicates a potential upside of 36% in Shoulder Innovations, Inc. (SI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Shoulder Innovations, Inc. (SI) Q1 2026 Earnings Call Transcript
Shoulder Innovations, Inc. (SI) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to a loss of $52.13 per share a year ago.
Generates First Quarter Net Revenue Growth of 65% Year-Over-Year GRAND RAPIDS, Mich., May 13, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the first quarter ended March 31, 2026.
Vancouver, British Columbia--(Newsfile Corp. - May 1, 2026) - SILICON METALS CORP. (CSE: SI) (OTC Pink: SLCND) (FSE: X6U0) ("Silicon Metals" or the "Company") is pleased to announce it has granted an aggregate of 603,100 stock options (collectively, the "Options") to certain directors of the Company for the purchase of up to 603,100 common shares in the capital of the Company (each a "Share"), pursuant to the Company's Stock Option Plan.
Vancouver, British Columbia--(Newsfile Corp. - April 27, 2026) - SILICON METALS CORP. (CSE: SI) (OTC Pink: SLCND) (FSE: X6U0) ("Silicon Metals" or the "Company") is pleased to announce that it intends to issue up to 4,444,444 units (the "Offering") at a price per unit of $0.135 (each, a "Unit").
Latest Addition to I-Series Product Line Follows a Successful Limited Market Release and FDAClearance of Additional Fracture Indications GRAND RAPIDS, Mich., April 27, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced full commercial launch of the InSet™ I-135RFX Humeral Stem ("InSet™ I-135RFX").
GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - SILICON METALS CORP. (CSE: SI) (FSE: X6U) ("Silicon Metals" or the "Company") is pleased to announce that it has executed a letter of intent dated as of April 17, 2026 (the "LOI"), with OIG Overseas Investment Group Ltd.
Vancouver, British Columbia--(Newsfile Corp. - April 9, 2026) - SILICON METALS CORP. (CSE: SI) (OTC Pink: SLCNF) (FSE: X6U) ("Silicon Metals" or the "Company") is pleased to announce that it has appointed Mr.
Medline (NASDAQ: MDLN - Get Free Report) and Shoulder Innovations (NYSE: SI - Get Free Report) are both manufacturing companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Profitability This table compares Medline and Shoulder Innovations' net
Vancouver, British Columbia--(Newsfile Corp. - April 1, 2026) - SILICON METALS CORP. (CSE: SI) (FSE: X6U) ("Silicon Metals" or the "Company") announces that, further to its press release dated March 26, 2026, it will consolidate the common shares of the Company (each, a "Share") on the basis of one (1) post-consolidation Share for every five (5) pre-consolidation Shares (the "Consolidation").
Vancouver, British Columbia--(Newsfile Corp. - March 26, 2026) - SILICON METALS CORP. (CSE: SI) (OTC Pink: SLCNF) (FSE: X6U) ("Silicon Metals" or the "Company") announces that it intends to consolidate the common shares of the Company (each, a "Share") on the basis of one (1) post-consolidation Share for every five (5) pre-consolidation Shares (the "Consolidation").
Medline (NASDAQ: MDLN - Get Free Report) and Shoulder Innovations (NYSE: SI - Get Free Report) are both manufacturing companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, analyst recommendations, profitability, risk and dividends. Earnings and Valuation This table compares Medline and Shoulder
Shoulder Innovations (NYSE: SI - Get Free Report) and Nanovibronix (NASDAQ: FEED - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, profitability and valuation. Institutional and Insider Ownership 16.4% of Nanovibronix shares
Shoulder Innovations (NYSE: SI - Get Free Report) and Predictive Oncology (NASDAQ: AGPU - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, earnings, dividends, profitability, valuation and risk. Profitability This table compares Shoulder Innovations and
Vancouver, British Columbia--(Newsfile Corp. - March 20, 2026) - SILICON METALS CORP. (CSE:SI) (FSE:X6U) ("Silicon Metals" or the "Company") is pleased to announce that the Company appointed current Director of the Company Mr.
Fourth Quarter Net Revenue Growth Accelerates to 65% Year-Over- Year GRAND RAPIDS, Mich., March 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the fourth quarter and full year ended December 31, 2025.
